Vivo Bio Tech Limited (BOM:511509)

Vivo Bio Tech Statistics

Total Valuation

Vivo Bio Tech has a market cap or net worth of INR 629.99 million. The enterprise value is 1.18 billion.

Market Cap	629.99M
Enterprise Value	1.18B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Vivo Bio Tech has 22.19 million shares outstanding. The number of shares has increased by 15.62% in one year.

Current Share Class	22.19M
Shares Outstanding	22.19M
Shares Change (YoY)	+15.62%
Shares Change (QoQ)	+15.47%
Owned by Insiders (%)	12.89%
Owned by Institutions (%)	n/a
Float	6.07M

Valuation Ratios

The trailing PE ratio is 12.15.

PE Ratio	12.15
Forward PE	n/a
PS Ratio	1.34
PB Ratio	0.65
P/TBV Ratio	0.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	26.17
EV / Sales	2.51
EV / EBITDA	8.58
EV / EBIT	16.77
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.58
Debt / EBITDA	4.10
Debt / FCF	n/a
Interest Coverage	1.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	3.61%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.20%
Revenue Per Employee	2.71M
Profits Per Employee	259,569
Employee Count	174
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Vivo Bio Tech has paid 12.84 million in taxes.

Income Tax	12.84M
Effective Tax Rate	22.13%

Stock Price Statistics

The stock price has decreased by -25.93% in the last 52 weeks. The beta is 0.00, so Vivo Bio Tech's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	-25.93%
50-Day Moving Average	29.57
200-Day Moving Average	34.56
Relative Strength Index (RSI)	44.88
Average Volume (20 Days)	19,791

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vivo Bio Tech had revenue of INR 471.83 million and earned 45.17 million in profits. Earnings per share was 2.34.

Revenue	471.83M
Gross Profit	403.37M
Operating Income	70.49M
Pretax Income	58.00M
Net Income	45.17M
EBITDA	137.78M
EBIT	70.49M
Earnings Per Share (EPS)	2.34

Balance Sheet

The company has 13.32 million in cash and 565.32 million in debt, with a net cash position of -551.99 million or -24.88 per share.

Cash & Cash Equivalents	13.32M
Total Debt	565.32M
Net Cash	-551.99M
Net Cash Per Share	-24.88
Equity (Book Value)	967.69M
Book Value Per Share	50.13
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 85.49%, with operating and profit margins of 14.94% and 9.57%.

Gross Margin	85.49%
Operating Margin	14.94%
Pretax Margin	12.29%
Profit Margin	9.57%
EBITDA Margin	29.20%
EBIT Margin	14.94%
FCF Margin	n/a

Dividends & Yields

Vivo Bio Tech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.62%
Shareholder Yield	-15.62%
Earnings Yield	7.17%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 7, 2005. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 7, 2005
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1